Abstract
Exfoliative (pseudoexfoliative) glaucoma is the most common secondary open-angle glaucoma worldwide. It develops from exfoliation (Exfoliation pseudoexfoliation) syndrome, a systemic elastosis is caused by single nucleotide polymorphisms of the lysyl oxidase-like protein which is an 1 important regulator of extracellular material turnover. Exfoliative syndrome is a systemic condition which is frequently associated with systemic and ocular vascular diseases. Clinical diagnosis of exfoliation syndrome is based on its typical appearance in the anterior segment of the eye. Both exfoliation syndrome and exfoliative glaucoma are frequently virtually unilateral, i.e., exfoliation material is visible in only one eye. This phenomenon however is in fact asymmetric clinical presentation since exfoliation material is detectable in the whole body and in both eyes even when its clinical presentation is asymmetric. Intraocular pressure in exfoliative glaucoma is typically higher than that in primary open-angle glaucoma, and its diurnal fluctuation is also increased. To control the disease, combined topical medication is frequently necessary. Laser trabeculoplasty and various filtering procedures are needed in many cases to control this progressive disease which is typically associated with severe visual field loss even at the time of diagnosis. Cataract development is also common, and due to the exfoliation-related zonular damage, cataract surgery in exfoliative eyes is associated with an increased risk of surgical complication.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ritch R, Schlotzer-Schrehardt U. Exfoliation syndrome. Surv Ophthalmol. 2001;45:265–315.
Ringvold A. Epidemiology of the pseudoexfoliation syndrome. A review. Acta Ophthalmol Scand. 1999;77:371–5.
Ritch R, Schlotzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res. 2003;22:253–75.
Thorleifsson G, Magnusson KP, Sulem P, et al. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science. 2007;317:1397–400.
Fingert JH, Alward WA, Kwon YH, Wang K, Streb LM. LOXL1 mutations are associated with exfoliation syndrome in patients from the Midwestern United States. Am J Ophthalmol. 2007;144:974–5.
Pasutto F, Krumbiegel M, Marin CY, et al. Associations of LOXL1 common sequence variants in German and Italian patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. Invest Ophthalmol Vis Sci. 2008;49:1459–63.
Ozaki M, Lee KYC, Vithana FN, et al. Association of LOXL1 gene polymorphism with pseudoexfoliation in the Japanese. Invest Ophthalmol Vis Sci. 2008;49:3976–80.
Hayashi H, Gotoh N, Ueda Y, Nakanishi H, Yoshimura N. Lysyl oxidase-like 1 polymorphism and exfoliation syndrome in the Japanese population. Am J Ophthalmol. 2008;145:582–5.
Schlotzer-Schrehardt U, Naumann GOH. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. Invest Ophthalmol Vis Sci. 1995;36:1750–64.
Naumann GOH, Schlötzer-Schrehardt U, Kuchle M. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Ophthalmology. 1998;105:951–68.
Koliakos GG, Konstas AGP, Schrehardt-Schloetzer U, Bufidis T, Georgiadis N, Ringvold A. Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol. 2002;134:879–83.
Visontai ZS, Horváth T, Kollai M, Holló G. Decreased cardiovagal regulation in exfoliation syndrome. J Glaucoma. 2008;17:133–8.
Holló G, Konstas AGP. Exfoliation syndrome: a systemic disease. In: Holló G, Konstas AGP, editors. Exfoliation syndrome and exfoliative glaucoma. Savona: Publicomm S.r.l; 2012. p. 87–96.
Prata TS, Rozenbaum I, de Moraes CGV, et al. Retinal vascular occlusions occur more frequently in the more affected eye in exfoliation syndrome. Eye. 2010;24:658–62.
Ritch R, Prata TS, de Moraes CGV, et al. Association of exfoliation syndrome and central retinal vein occlusion: an ultrastructural analysis. Acta Ophthalmol. 2010;88:91–5.
Holló G, Gál A, Kóthy P, Molnár JM. LOXL1 gene sequence variants and vascular disease in exfoliation syndrome and exfoliative glaucoma. J Glaucoma. 2011;20:143–7.
Visontai Z, Merisch B, Kollai M, Holló G. Increase of carotid artery stiffness and decrease of baroreflex sensitivity in exfoliation syndrome and glaucoma. Br J Ophthalmol. 2006;90:563–7.
Mitchell P, Wang JJ, Smith W. Association of pseudoexfolation syndrome with increased vascular risk. Am J Ophthalmol. 1997;124:85–687.
Tarkkanen A, Kivelä T. Cumulative incidence of converting from clinically unilateral to bilateral exfoliation syndrome. J Glaucoma. 2004;13:181–4.
Puska P. Unilateral exfoliation syndrome: conversion to bilateral exfoliation and to glaucoma. A prospective 10-year follow-up study. J Glaucoma. 2002;11:517–24.
Konstas AGP, Matziris DA, Stewart WC. Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;28:111–7.
Konstas AGP, Holló G, Astakhov YS, et al. Presentation and long-term follow-up of exfoliation glaucoma in Greece, Spain. Russia and Hungary. Eur J Ophthalmol. 2006;16:60–6.
Thygesen J. Ocular clinical findings in exfoliation syndrome. In: Holló G, Konstas AGP, editors. Exfoliation syndrome and exfoliative glaucoma. 2nd ed. Savona: Dogma S.r.l; 2008. p. 105–12.
Vesti E, Kivela AT. Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res. 2000;19:268–345.
Konstas AGP, Tsironi S, Kozobolis VP. Medical therapy of exfoliative glaucoma. In: Holló G, Konstas AGP, editors. Exfoliation syndrome and exfoliative glaucoma. 2nd ed. Savona: Publicomm S.r.l; 2012. p. 137–47.
Konstas AGP, Holló G, Akopov EL, et al. Factors associated with long-term progression or stability in exfoliation glaucoma. Arch Ophthalmol. 2004;122:29–33.
Konstas AGP, Tsironi S, Ritch R. Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma. Compr Ophthalmol Update. 2006;7:131–41.
Takki KK, Klemetti A, Valle O. The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland. Graefes Arch Clin Exp Ophthalmol. 1982;218:83–7.
Teus MA, de Benito-Llopis L. Update on cataract surgery in exfoliation syndrome. In: Holló G, Konstas AGP, editors. Exfoliation syndrome and exfoliative glaucoma. Savona: Publicomm S.r.l; 2012. p. 127–35.
Blika S, Saunte E. Timolol maleate in the treatment of glaucoma simplex and glaucoma capsulare. A three-year follow up study. Acta Ophthalmol (Copenh). 1982;60:967–76.
Konstas AG, Matziris DA, Gate EA, Stewart WC. Effect of timolol on the diurnal intraocular pressure in exfoliation and primary open-angle glaucoma. Arch Ophthalmol. 1997;115:975–9.
Heijl A, Strahlman E, Sverrisson T, et al. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension. Ophthalmology. 1997;104:137–42.
Konstas AGP, Maltezos A, Bufidis T, Hudgins AG, Stewart WC. Twenty-four hour control of intraocular pressure with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Eye. 2000;14:73–7.
Parmaksiz S, Yuksel N, Karabas VL, Ozkan B, Demirci G, Caglar Y. A comparison of travoprost, latanoprost, and the fixed combination of dorzolamide and timolol in patients with pseudoexfoliation glaucoma. Eur J Ophthalmol. 2006;16:73–80.
Konstas AG, Kozobolis VP, Tersis I, Leech J, Stewart WC. The efficacy and safety of the timolol/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma. Eye. 2003;17:41–6.
Konstas AG, Mylopoulos N, Karabatsas CH, et al. Diurnal intraocular pressure reduction with latanoprost 0.005 % compared to timolol maleate 0.5 % as monotherapy in subjects with exfoliation glaucoma. Eye. 2004;18:893–9.
Konstas AGP, Kozobolis VP, Katsimpris IE, et al. Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients. Ophthalmology. 2007;114:653–7.
Konstas AGP, Holló G, Irkec M, et al. Diurnal IOP control with bimatoprost vs latanoprost in exfoliative glaucoma: a crossover observer-masked 3-center study. Br J Ophthalmol. 2007;91:757–60.
Stewart WC, Konstas AGP, Nelson LA, Kruft B. Meta-analysis of 24-hour intraocular pressure studies evaluating efficacy of glaucoma medicines. Ophthalmology. 2008;115:1117–22.
Petounis A, Mylopoulos N, Kandarakis A, Andreanos D, Dimitrakoulias N. Comparison of additive intraocular pressure-lowering effect of latanoprost and dorzolamide when added to timolol in patients with open-angle glaucoma or ocular hypertension: a randomized open-label, multicenter study in Greece. J Glaucoma. 2001;10:316–24.
Odberg T. Laser therapy of exfoliative glaucoma. In: Holló G, Konstas AGP, editors. Exfoliation syndrome and exfoliative glaucoma. 2nd ed. Savona: Publicomm S.r.l; 2012. p. 149–55.
Odberg T, Sandvik L. The medium and long-term efficacy of primary argon laser trabeculoplasty in avoiding topical medication in open angle glaucoma. Acta Ophthalmol Scand. 1999;77:176–81.
Threlkeld A, Hertzmark E, Sturm RT, et al. Comparative study of the efficacy of argon laser trabeculoplasty for exfoliation and primary open-angle glaucoma. J Glaucoma. 1996;5:311–6.
Higginbotham EJ, Richardson TM. Response of exfoliation glaucoma to laser trabeculoplasty. Br J Ophthalmol. 1986;70:837–9.
Psilas P, Prevezas D, Petroutsos G, et al. Comparative study of argon laser trabeculoplasty in primary open-angle and pseudoexfoliation glaucoma. Ophthalmologica. 1989;198:57–63.
Tuulonen A, Niva A-K, Alanko HI. A controlled five-year follow-up study of laser trabeculoplasty as primary therapy for open-angle glaucoma. Am J Ophthalmol. 1987;104:334–8.
Hodge WG, Damji KF, Rock W, Buhrmann R, Bowel AM, Pan Y. Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial. Br J Ophthalmol. 2005;89:1157–60.
Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma. Arch Ophthalmol. 2003;121:957–60.
Kozobolis VP, Konstas AGP. Filtering surgery in exfoliative glaucoma. In: Holló G, Konstas AGP, editors. Exfoliation syndrome and exfoliative glaucoma. 2nd ed. Savona: Publicomm S.r.l; 2012. p. 157–63.
Tornqvist G, Drolsum L. Trabeculectomies. A long-term study. Acta Ophthalmol (Copenh). 1991;69:450–4.
Popovic V, Sjostrand J. Course of exfoliation and simplex glaucoma after primary trabeculectomy. Br J Ophthalmol. 1999;83:305–10.
Konstas AGP, Jay JL, Marshall GE, Lee WR. Prevalence, diagnostic features and the response to trabeculectomy in exfoliation glaucoma. Ophthalmology. 1993;100:619–27.
Drolsum L. Deep sclerectomy in patients with capsular glaucoma. Acta Ophthalmol Scand. 2003;81:567–72.
Kozobolis VP, Christodoulakis EV, Tzanakis N, Zacharopoulos I, Pallikaris IG. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma. 2002;11:287–93.
Shaarawy T, Nguyen C, Schnyder C, Mermoud A. Five year results of viscocanalostomy. Br J Ophthalmol. 2003;87:441–5.
Wishart PK, Wishart MS, Porooshani H. Viscocanalostomy and deep sclerectomy for the surgical treatment of glaucoma: a long-term follow-up. Acta Ophthalmol Scand. 2003;81:343–8.
Jacobi PC, Dietlein TS, Krieglstein GK. Comparative study of trabecular aspiration vs trabeculectomy in glaucoma triple procedure to treat pseudoexfoliation glaucoma. Arch Ophthalmol. 1999;117:1311–8.
Ritch R, Konstas AGP, Schlötzer-Schrehardt U. Exfoliation syndrome and exfoliative glaucoma. In: Shaarawy TM, Sherwood MB, Hitchings RA, Crowston JG, editors. Glaucoma: medical diagnosis and therapy, vol. 1. London: Saunders; 2009. p. 339–48.
Kanthan GL, Mitchell P, Burlutsky G, Rochtchina E, Wang JJ. Pseudoexfoliation syndrome and the long-term incidence of cataract and cataract surgery: the blue mountains eye study. Am J Ophthalmol. 2013;155:83–88.e1.
Woodfield AS, Gower EW, Cassard SD, Ramanthan S. Intraoperative phacoemulsification complication rates of second and third year ophthalmology residents a 5-year comparison. Ophthalmology. 2011;118:954–8.
Shingleton BJ, Marvin AC, Heier JS, O’Donoghue MW, Laul A, Wolff B, Rowland A. Pseudoexfoliation: high risk factors for zonule weakness and concurrent vitrectomy during phacoemulsification. J Cataract Refract Surg. 2010;36:1261–9.
Carpel EF. Pupillary dilation in eyes with pseudoexfoliation syndrome. Am J Ophthalmol. 1988;105:692–4.
Myers WG, Shugar K. Optimizing the intracameral dilation regimen for cataract surgery: prospective randomized comparison of 2 solutions. J Cataract Refract Surg. 2009;35:273–6.
Akman A, Yilmaz G, Oto S, Akora YA. Comparison of various pupila dilation methods for phacoemulsification in eyes with a small pupil secondary to pseudoexfoliaton. Ophthalmology. 2004;111:1693–8.
Marques DM, Marques FF, Osher RH. Subtle signs of zonular damage. J Cataract Refract Surg. 2004;30:1295–9.
Küchle M, Viestenz A, Martus P, Andel A, Junemann A, Naumann A, Naumann GO. Anterior chamber depth and complications during cataract surgery in eyes with pseudoexfoliation syndrome. Am J Ophthalmol. 2000;129:281–5.
Hasanee K, Ahmed II K. Capsular tension rings: update on endocapsular support devices. Ophthalmol Clin North Am. 2006;19:507–19.
Werner L, Zaugg B, Neuhann T, Burrow M, Tetz M. In the bag capsular tension ring and intraocular lens subluxation or dislocation a series of 23 cases. Ophthalmology. 2012;119:266–71.
Schumacher S, Nguyen NX, Küchle M, Naumann GOH. Quantification of aqueous flare after phacoemulsification with intraocular lens implantation in eyes with pseudoexfoliation syndrome. Arch Ophthalmol. 1999;117:733–5.
Shingleton BJ, Laul A, Nagao K, Wolff B, O’Donoghue M, Eagan E, Flattem N, Desai-Bartoli S. Effect of phacoemulsification on intraocular pressure in eyes with pseudoexfoliation: single-surgeon series. J Cataract Refract Surg. 2008;34:1834–41.
Hayashi H, Hayashi K, Nakao F, Hayashi F. Anterior capsule contraction and intraocular lens dislocation in eyes with pseudoexfoliation syndrome. Br J Ophthalmol. 1998;82:1429–32.
Hayashi K, Yoshida M, Hirata A, Hayashi H. Anterior capsule relaxing incisions with neodymium YAG laser for patients at high risk for anterior capsule contraction. J Cataract Refract Surg. 2011;37:97–103.
Lorente R, de Rojas V, Vazquez de Parga P, Moreno C, Landaluce ML, Dominguez R, Lorente B. Management of late spontaneous in-the-bag intraocular lens dislocation: retrospective analysis of 45 cases. J Cataract Refract Surg. 2010;36:1270–82.
Shingleton BJ, Wooler KB, Bourne CI, O’Donoghue MW. Combined cataract and trabeculectomy surgery in eyes with pseudoexfoliation glaucoma. J Cataract Refract Surg. 2011;37:1961–70.
Acknowledgments
This work is supported in part by a Pythagoras grant (Dr. Konstas) and a Horizon Award, Allergan, Inc., and Edith C. Blum Foundation, New York, NY (Dr. Ritch).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Konstas, AG.P., Holló, G., Teus, M.A., Ritch, R. (2014). Exfoliation Syndrome and Glaucoma. In: Samples, J., Schacknow, P. (eds) Clinical Glaucoma Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4172-4_17
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4172-4_17
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4171-7
Online ISBN: 978-1-4614-4172-4
eBook Packages: MedicineMedicine (R0)